Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist

Nintedanib-induced diarrhoea may be controlled by ramosetron by modulation of intestinal motility as for irritable bowel syndrome #pulmonaryfibrosis https://bit.ly/3OQVAII

Detalles Bibliográficos
Autores principales: Arai, Toru, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511131/
https://www.ncbi.nlm.nih.gov/pubmed/36171988
http://dx.doi.org/10.1183/23120541.00242-2022
_version_ 1784797596036890624
author Arai, Toru
Inoue, Yoshikazu
author_facet Arai, Toru
Inoue, Yoshikazu
author_sort Arai, Toru
collection PubMed
description Nintedanib-induced diarrhoea may be controlled by ramosetron by modulation of intestinal motility as for irritable bowel syndrome #pulmonaryfibrosis https://bit.ly/3OQVAII
format Online
Article
Text
id pubmed-9511131
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-95111312022-09-27 Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist Arai, Toru Inoue, Yoshikazu ERJ Open Res Research Letters Nintedanib-induced diarrhoea may be controlled by ramosetron by modulation of intestinal motility as for irritable bowel syndrome #pulmonaryfibrosis https://bit.ly/3OQVAII European Respiratory Society 2022-09-26 /pmc/articles/PMC9511131/ /pubmed/36171988 http://dx.doi.org/10.1183/23120541.00242-2022 Text en Copyright ©The authors 2022 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org)
spellingShingle Research Letters
Arai, Toru
Inoue, Yoshikazu
Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title_full Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title_fullStr Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title_full_unstemmed Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title_short Two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
title_sort two cases of nintedanib-induced diarrhoea treated using a 5-hydroxytryptamine type 3 receptor antagonist
topic Research Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511131/
https://www.ncbi.nlm.nih.gov/pubmed/36171988
http://dx.doi.org/10.1183/23120541.00242-2022
work_keys_str_mv AT araitoru twocasesofnintedanibinduceddiarrhoeatreatedusinga5hydroxytryptaminetype3receptorantagonist
AT inoueyoshikazu twocasesofnintedanibinduceddiarrhoeatreatedusinga5hydroxytryptaminetype3receptorantagonist

Ejemplares similares